Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas

被引:25
作者
Bari, Alessia [1 ]
Tadmor, Tamar [2 ]
Sacchi, Stefano [1 ]
Marcheselli, Luigi [1 ]
Liardo, Eliana Valentina [1 ]
Pozzi, Samantha [1 ]
Luminari, Stefano [1 ]
Baldini, Luca [3 ]
Marmiroli, Sandra [4 ]
Federico, Massimo [1 ]
Polliack, Aaron [5 ,6 ]
机构
[1] Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, I-41124 Modena, Italy
[2] Technion Israel Inst Technol, Rappaport Fac Med, Bnai Zion Med Ctr, Div Hematol, Haifa, Israel
[3] Univ Milan, Fdn IRCCS Ca Granda, Div Hematol, I-20122 Milan, Italy
[4] Univ Modena & Reggio Emilia, Dept Surg Med Odontoiatr & Morphol Sci, Cellular Signaling Lab, I-41124 Modena, Italy
[5] Hadassah Univ Hosp, Dept Hematol, IL-91120 Jerusalem, Israel
[6] Hebrew Univ Jerusalem, Sch Med, IL-91010 Jerusalem, Israel
关键词
Monocytosis; Non-Hodgkin lymphoma; Peripheral T-cell lymphoma; Prognostic value; Overall survival; NON-HODGKINS-LYMPHOMA; UNSPECIFIED PTCL-U; ABSOLUTE MONOCYTE; LYMPHOPENIA; EXPRESSION; DIAGNOSIS; COUNT; MODEL; SCORE; SIGNATURES;
D O I
10.1016/j.leukres.2013.01.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this retrospective study we evaluated the prognostic impact of peripheral blood monocytosis in patients with T-cell non Hodgkin lymphomas with "aggressive-typically nodal presentation". In this dataset monocytes >0.8 x 10(9)/L had a strong and statistically significant negative impact on overall survival (OS). In univariate analysis several parameters, including age >60 years, advanced stage, bone marrow involvement, ECOG PS > 1, high LDH level, monocytes >0.8 x 10(9)/L, hemoglobin < 120 g/L, albumin < 35 g/L) had a negative influence on outcome, but in multivariate analysis, monocytosis alone had a stronger association with poor OS. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:619 / 623
页数:5
相关论文
共 36 条
  • [21] Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma
    Porrata, Luis F.
    Ristow, Kay
    Habermann, Thomas M.
    Ozsan, Nazan
    Dogan, Ahmet
    Macon, William
    Colgan, Joseph P.
    Witzig, Thomas E.
    Inwards, David J.
    Ansell, Stephen M.
    Micallef, Ivana N.
    Johnston, Patrick B.
    Nowakowski, Grzegorz S.
    Thompson, Carrie
    Markovic, Svetomir N.
    [J]. LEUKEMIA & LYMPHOMA, 2012, 53 (11) : 2159 - 2165
  • [22] Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma
    Porrata, Luis F.
    Ristow, Kay
    Colgan, Joseph P.
    Habermann, Thomas M.
    Witzig, Thomas E.
    Inwards, David J.
    Ansell, Stephen M.
    Micallef, Ivana N.
    Johnston, Patrick B.
    Nowakowski, Grzegorz S.
    Thompson, Carrie
    Markovic, Svetomir N.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (02): : 262 - 269
  • [23] PARTIAL RESIDUALS FOR THE PROPORTIONAL HAZARDS REGRESSION-MODEL
    SCHOENFELD, D
    [J]. BIOMETRIKA, 1982, 69 (01) : 239 - 241
  • [24] A PREDICTIVE MODEL FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA
    SHIPP, MA
    HARRINGTON, DP
    ANDERSON, JR
    ARMITAGE, JO
    BONADONNA, G
    BRITTINGER, G
    CABANILLAS, F
    CANELLOS, GP
    COIFFIER, B
    CONNORS, JM
    COWAN, RA
    CROWTHER, D
    DAHLBERG, S
    ENGELHARD, M
    FISHER, RI
    GISSELBRECHT, C
    HORNING, SJ
    LEPAGE, E
    LISTER, TA
    MEERWALDT, JH
    MONTSERRAT, E
    NISSEN, NI
    OKEN, MM
    PETERSON, BA
    TONDINI, C
    VELASQUEZ, WA
    YEAP, BY
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) : 987 - 994
  • [25] Tadmor T, 2012, HAEMATOLOGICA, V97, P127
  • [26] Tadmor T, 2011, ANN ONCOL, V22, P223
  • [27] Myeloid-derived suppressor cells - their role in haemato-oncological malignancies and other cancers and possible implications for therapy
    Tadmor, Tamar
    Attias, Dina
    Polliack, Aaron
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (05) : 557 - 567
  • [28] Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia/lymphoma (ATLL)
    Takasaki, Yumi
    Iwanaga, Masako
    Tsukasaki, Kunihiro
    Kusano, Miyuki
    Sugahara, Kazuyuki
    Yamada, Yasuaki
    Kamihira, Shimeru
    Ikeda, Shuichi
    Tomonaga, Masao
    [J]. LEUKEMIA RESEARCH, 2007, 31 (06) : 751 - 757
  • [29] TOKIOKA T, 1994, HAEMATOLOGIA, V26, P1
  • [30] Vardiman JW., 2008, WHO CLASSIFICATION T